Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Malignancy-related deaths among HIV-infected patients.

d'Arminio Monforte A.

Clin Infect Dis. 2009 Mar 1;48(5):640-1. Review. No abstract available.


Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, Chêne G, Morlat P; Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group; Mortavic Study Group.

Clin Infect Dis. 2009 Mar 1;48(5):633-9.


Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.

Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, Rauch A, Probst-Hensch NM, Bouchardy C, Levi F, Franceschi S; Swiss HIV Cohort.

AIDS. 2008 Oct 18;22(16):2135-41. doi: 10.1097/QAD.0b013e32831103ad.


Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Salmon D, Cacoub P, Chêne G; ANRS EN19 Mortalité Study Group and Mortavic1.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):590-8. doi: 10.1097/QAI.0b013e31817efb54.


Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004.

Bonnet F, Chêne G, Thiébaut R, Dupon M, Lawson-Ayayi S, Pellegrin JL, Dabis F, Morlat P; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

HIV Med. 2007 Nov;8(8):547-54.


Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe.

Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S; Immunosuppression and Cancer Study Group.

Eur J Cancer. 2007 Sep;43(14):2117-23. Epub 2007 Aug 30.


AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.

Silverberg MJ, Abrams DI.

Curr Opin Oncol. 2007 Sep;19(5):446-51. Review.


HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO3 AQUITAINE Study Group.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):72-7.


Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM.

Lancet. 2007 Jul 7;370(9581):59-67. Review.


Cancer incidence before and after kidney transplantation.

Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE.

JAMA. 2006 Dec 20;296(23):2823-31.


Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV.

Ann Intern Med. 2006 Sep 19;145(6):397-406.


Trends in cancer risk among people with AIDS in the United States 1980-2002.

Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ; HIV/AIDS Cancer Match Study.

AIDS. 2006 Aug 1;20(12):1645-54.


HIV infection and tobacco smoking behaviour: prospects for prevention? ANRS CO3 Aquitaine Cohort, 2002.

Bénard A, Tessier JF, Rambeloarisoa J, Bonnet F, Fossoux H, Neau D, Dutronc H, Lazaro E, Dabis F, Chêne G.

Int J Tuberc Lung Dis. 2006 Apr;10(4):378-83.


Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.

Bonnet F, Balestre E, Thiébaut R, Morlat P, Pellegrin JL, Neau D, Dabis F; Groupe d'Epidemiologie Clinique du SIDA en Aquitaine.

Clin Infect Dis. 2006 Feb 1;42(3):411-7. Epub 2005 Dec 27.


Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.


Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.


Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome.

Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, Precone D, Gelatti U, Asensi V, Vaccher E; HIV HCC Cooperative Italian-Spanish Group.

AIDS. 2004 Nov 19;18(17):2285-93.


Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group.

Int J Epidemiol. 2005 Feb;34(1):121-30. Epub 2004 Nov 23.


Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P.

Cancer. 2004 Jul 15;101(2):317-24.


Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM.

Blood. 2004 Aug 15;104(4):942-7. Epub 2004 Apr 29.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk